DSIP 15mg

Overview

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide composed of nine amino acids, first identified in the cerebral blood of laboratory animals. It has been synthesized for research purposes and is studied exclusively in in vitro and preclinical environments. Laboratory investigations focus on DSIP’s influence on neuroendocrine signaling, peptide-receptor interactions, and molecular mechanisms associated with stress adaptation and homeostasis.

Specifications

• Unit Size: 15 mg per vial

• Form: Lyophilized powder

• Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.

• Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available upon request.

Research Context

Controlled laboratory and non-clinical studies have explored DSIP in relation to:

• Peptide signaling and neuroendocrine communication pathways

• Modulation of stress-response and homeostatic feedback systems

• Regulation of pituitary and hypothalamic peptide activity in experimental models

• Peptide-receptor binding and neurochemical response mapping in vitro

All findings are derived from non-human and preclinical studies. No claims are made regarding DSIP’s safety, efficacy, or suitability for human or veterinary use.

Intended Use / Restrictions

• For laboratory research use only

• Not for human or veterinary use

• Not a drug, dietary supplement, or medical device

• Buyer must be a qualified researcher or institution and assumes all responsibility for lawful handling and regulatory compliance.

Important Notice

The information provided is for scientific and educational purposes only. DSIP is not approved for human or veterinary administration and is not intended to diagnose, treat, or prevent any condition. The seller makes no representations regarding the safety or effectiveness of this material for any clinical purpose. Proper storage, handling, and disposal must follow institutional biosafety guidelines.